A. A. sukahar, “RISK OF HBV REACTIVATION DURING THERAPIES FOR HCC: A SYSTEMATIC REVIEW”, JARMHS, vol. 9, no. 10, pp. 111–116, Oct. 2023, doi: 10.53555/t0qwb657.